Insulet (PODD) Misses Q3 EPS by 7c
Get Alerts PODD Hot Sheet
Price: $142.28 -3.53%
EPS Growth %: +28.2%
Financial Fact:
Gross profit: 55.64M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +28.2%
Financial Fact:
Gross profit: 55.64M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q3 EPS of ($0.33), $0.07 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $87.3 million versus the consensus estimate of $83.56 million.
Guidance:
For the year ending December 31, 2015, the Company is raising the low end of its revenue expectations to a range of $310 to $320 million, from $305 to $320 million. This represents year-over-year revenue growth of 9% at the mid-point of the range.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
- Activist investor presses Xerox to review financial services arm - Bloomberg
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share